SAS Features Case Study of Extensive Relationship With Clearstone Central Laboratories
Clearstone Central Laboratories announced that business analytics software giant SAS has recently published a customer success story that features the extensive history between the two companies working alongside to accelerate clinical trails with clean, on-time data.
Every year, pharmaceutical companies deliver an ever-broadening range of medications that improve patient health and save countless lives. But the clinical trial phase of drug development is a risky proposition—expensive, highly regulated, and critical to the market approval of a drug. Increasingly, pharmaceutical executives are turning to Clearstone to manage this complex process of creating, aggregating, and delivering highly structured, reliable, and timely data.
SAS has allowed Clearstone to effectively work with large volumes of data that previously would require substantially more time and resources. Multiple tasks can be run simultaneously, allowing for time efficiencies. This additional flexibility has enabled Clearstone to rapidly scale its business around the world and expand its service offering to include data mining and analytical services that allow Clearstone to predict aspects of a trial using historical data.
- Podcast interview with Hacene Mekerri
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
